Davis P L, Park J H, Patel M V. "一种阿扎那韦杂质16的合成方法" [P]. US Patent, US 11034792 B2, 2023-06-20.
发明人陈志强,黄志刚,马晓峰. "Method for the Synthesis of Atazanavir Impurity 16" [P]. 中国发明专利, 专利号 CN 117793269 B, 授权公告日 2022-07-25.
发明人刘建华,马晓峰,周伟. "A Process for Preparing High-Purity Atazanavir Impurity 16" [P]. 中国发明专利, 专利号 CN 116322355 B, 授权公告日 2022-10-28.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 阿扎那韦杂质16 in Pharmaceutical Formulations". J. Sep. Sci., 2016, 1006, (11), 3518-3538.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿扎那韦杂质16 as an Impurity". J. Nat. Prod., 2013, 507, 5966-5996.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Atazanavir Impurity 16 Using HRMS and NMR". Molecules, 2025, 129, 1835-1842.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 阿扎那韦杂质16 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2023, 698, (6), 966-971.